Vol. 35 No. 6 2007
■ ORIGINAL ARTICLES
Effect of a disease-modifying antirheumatic drug Iguratimod (T-614) on inflammatory cytokine production
M. Yamamoto, et al.
Jpn Pharmacol Ther 2007 35(6) 551-9
Immunopharmacological
studies of a disease-modifying antirheumatic drug Iguratimod (T-614)
─Its effect on immunoglobulin production and lymphocyte proliferation─
T. Akase, et al.
Jpn Pharmacol Ther 2007 35(6) 561-9
Effect of a disease-modifying antirheumatic drug Iguratimod (T-614) on chronic
arthritis in experimental animals
N. Urata, et al.
Jpn Pharmacol Ther 2007 35(6) 571-82
Comparative study for pharmacokinetics of lenograstim (RH)(rG-CSF produced by serum-containing
culture system) and lenograstim (rG-CSF produced by serum-free culture system)
R. Shiokawa, et al.
Jpn Pharmacol Ther 2007 35(6) 583-6
Development of antral lesions Induced by alendronate in rat stomachs
─Effect of Irsogladine
Malate─
E. Aihara, et al.
Jpn Pharmacol Ther 2007 35(6) 587-90
Enzymatically prepared inulin-type fructans treatment increased bone mineral density in rats given low Ca diets
Y. Tomono, et al.
Jpn Pharmacol Ther 2007 35(6) 601-5
Bioequivalence study for nizatizine tablets and nizatizine capsules in humans
J. Kaneko, et al.
Jpn Pharmacol Ther 2007 35(6) 609-16
Phase III controlled clinical trial of Z-205
─Evaluation of the clinical utility
of Z-205 compared with MGV-5─
T. Hibi, et al.
Jpn Pharmacol Ther 2007 35(6) 617-46
Antidiabetic effect and safety of Long-term ingestion of "Ashitaba"(angelica
keiskei) powder containing chalcone (4HD)on borderline mild hyperglycemia
H. Oonogi, et al.
Jpn Pharmacol Ther 2007 35(6) 647-60
Lowering effects on visceral fat of the OTPP (oolong tea polymerized polyphenols)
enriched oolong tea (FOSHU "KURO-oolong tea OTPP"（in over weight volunteers
J. Nakamura, et al.
Jpn Pharmacol Ther 2007 35(6) 661-71
Effect of soluble coffee containing mannooligosaccharides on human body fat by long-term ingestion
T. Kumao, et al.
Jpn Pharmacol Ther 2007 35(6) 673-9
